CYSTIC FIBROSIS
Basic Information
- Primary DI
- D-9017BF
- Basic UDI-DI Code
- B-9017BF
- Reference
- RC-CFHS096-I
- Device Types
- None provided
- Regulation
- Eu Ivdd
- Classification
- Eu Ivd General
- Status
- No Longer On The Market
- Manufacturer
- NimaGen BV
Additional Description
The intended purpose of this assay is NGS library preparation for Illuminaยฎ sequencing of human CFTR Hotspots; to aid in diagnosis of (the congenital predisposition to) cystic fibrosis by detecting sequence variants. The assay is designed for use with DNA extracted from peripheral blood. Specimens should have an absorbance ratio (260/280) of ~1.8, regardless of the extraction method used. The assay provides reagents for Multiplex Amplicon based NGS library preparation and is for professional use only. The kit is based on the patented Reverse Complement PCR technology, providing a safe, robust and simple workflow, combining multiplex amplification in a single reaction, decreasing risk for PCR contamination and sample swapping.
CND Nomenclature Codes
| Code | Description |
|---|---|
| W0106010101 | CYSTIC FIBROSIS |
Available In Countries
Similar Devices
Other on-the-market devices with the same classification (Eu Ivd General) and regulation (EU IVDD).